<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>D-012090LB</udiDi>
    <basicUdiDi>B-012090LB</basicUdiDi>
    <tradeName>Restylane Refyne</tradeName>
    <deviceName>Restylane Refyne</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>012090</reference>
    <placedOnMarketCountry>Austria</placedOnMarketCountry>
    <lastUpdated>2026-07-05T13:08:59.532Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-012089LS</udiDi>
    <basicUdiDi>B-012089LS</basicUdiDi>
    <tradeName>Restylane Volyme</tradeName>
    <deviceName>Restylane Volyme</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>012089</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-05T13:08:57.933Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-012062L6</udiDi>
    <basicUdiDi>B-012062L6</basicUdiDi>
    <tradeName>Restylane Kysse</tradeName>
    <deviceName>Restylane Kysse</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>012062</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-05T13:08:55.525Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-012061L4</udiDi>
    <basicUdiDi>B-012061L4</basicUdiDi>
    <tradeName>Restylane Skinboosters Vital Lidocaine</tradeName>
    <deviceName>Restylane Skinboosters Vital Lidocaine</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>012061</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-05T13:08:53.920Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-012060L2</udiDi>
    <basicUdiDi>B-012060L2</basicUdiDi>
    <tradeName>Restylane Skinboosters Vital Lidocaine</tradeName>
    <deviceName>Restylane Skinboosters Vital Lidocaine</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>012060</reference>
    <placedOnMarketCountry>Poland</placedOnMarketCountry>
    <lastUpdated>2026-07-05T13:08:53.119Z</lastUpdated>
  </row>
  <row>
    <udiDi>D-012059LH</udiDi>
    <basicUdiDi>B-012059LH</basicUdiDi>
    <tradeName>Restylane Skinboosters Vital Lidocaine</tradeName>
    <deviceName>Restylane Skinboosters Vital Lidocaine</deviceName>
    <manufacturerName>Q-Med AB</manufacturerName>
    <manufacturerSrn>SE-MF-000008549</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>012059</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-05T13:08:51.535Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809684739617</udiDi>
    <basicUdiDi>880968473961COREFILLBS</basicUdiDi>
    <tradeName>CORE FILL PLUS</tradeName>
    <deviceName>CORE FILL PLUS</deviceName>
    <manufacturerName>YURIM MEDICAL Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000009011</manufacturerSrn>
    <authorisedRepresentativeName>SOAR &amp; PARTNERS Sp. z o.o.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>PL-AR-000040956</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CORE FILL PLUS SUB-Q</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-03T17:59:35.506Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809448822760</udiDi>
    <basicUdiDi>88094488TTP_CosmeticGS</basicUdiDi>
    <tradeName>08809448822760</tradeName>
    <deviceName>TTP</deviceName>
    <manufacturerName>JMBIOTECH</manufacturerName>
    <manufacturerSrn>KR-MF-000029867</manufacturerSrn>
    <authorisedRepresentativeName>AF Pharma Service Europe SL</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>ES-AR-000018076</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0302</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – NON RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>TTP 324(13)-32G</reference>
    <placedOnMarketCountry>Belgium</placedOnMarketCountry>
    <lastUpdated>2026-07-03T17:57:33.717Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809684749128</udiDi>
    <basicUdiDi>880968473961COREFILLBS</basicUdiDi>
    <tradeName>CORE FILL PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>YURIM MEDICAL Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000009011</manufacturerSrn>
    <authorisedRepresentativeName>SOAR &amp; PARTNERS Sp. z o.o.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>PL-AR-000040956</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>COREFILL PLUS DEEP</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T11:44:19.144Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809684749135</udiDi>
    <basicUdiDi>880968473961COREFILLBS</basicUdiDi>
    <tradeName>CORE FILL PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>YURIM MEDICAL Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000009011</manufacturerSrn>
    <authorisedRepresentativeName>SOAR &amp; PARTNERS Sp. z o.o.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>PL-AR-000040956</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>CORE FILL PLUS FINE</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T11:44:19.117Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809684749142</udiDi>
    <basicUdiDi>880968473961COREFILLBS</basicUdiDi>
    <tradeName>CORE FILL PLUS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>YURIM MEDICAL Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000009011</manufacturerSrn>
    <authorisedRepresentativeName>SOAR &amp; PARTNERS Sp. z o.o.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>PL-AR-000040956</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>COREFILL PLUS AQ</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-03T11:44:19.056Z</lastUpdated>
  </row>
  <row>
    <udiDi>03664948000866</udiDi>
    <basicUdiDi>3664948ARTFILLERWL</basicUdiDi>
    <tradeName>ART FILLER LIPS SOFT</tradeName>
    <deviceName>ART FILLER VOLUME</deviceName>
    <manufacturerName>Laboratoires Fill-Med</manufacturerName>
    <manufacturerSrn>FR-MF-000007907</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>1V3084</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-01T10:57:11.654Z</lastUpdated>
  </row>
  <row>
    <udiDi>03664948000859</udiDi>
    <basicUdiDi>3664948NCTF135HADN</basicUdiDi>
    <tradeName>NCTF 135 HA</tradeName>
    <deviceName>NCTF 135 HA</deviceName>
    <manufacturerName>Laboratoires Fill-Med</manufacturerName>
    <manufacturerSrn>FR-MF-000007907</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0301</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>3F4010</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-01T10:57:10.037Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809369094093</udiDi>
    <basicUdiDi>880936909BNC004HE</basicUdiDi>
    <tradeName>JUVEGEL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid Dermal Filler with Polynucleotide</deviceName>
    <manufacturerName>BNC KOREA, Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000008321</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T03:16:56.814Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809369094086</udiDi>
    <basicUdiDi>880936909BNC004HE</basicUdiDi>
    <tradeName>JUVEGEL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid Dermal Filler with Polynucleotide</deviceName>
    <manufacturerName>BNC KOREA, Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000008321</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T03:16:55.625Z</lastUpdated>
  </row>
  <row>
    <udiDi>08809369093355</udiDi>
    <basicUdiDi>880936909BNC004HE</basicUdiDi>
    <tradeName>JUVEGEL</tradeName>
    <deviceName>Cross-linked Hyaluronic Acid Dermal Filler with Polynucleotide</deviceName>
    <manufacturerName>BNC KOREA, Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000008321</manufacturerSrn>
    <authorisedRepresentativeName>Javitech Consulting GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000045915</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Germany</placedOnMarketCountry>
    <lastUpdated>2026-07-01T03:16:28.037Z</lastUpdated>
  </row>
  <row>
    <udiDi>08806138000040</udiDi>
    <basicUdiDi>880613800004DC</basicUdiDi>
    <tradeName>Neuramis Volume Lidocaine</tradeName>
    <deviceName>Neuramis Volume Lidocaine</deviceName>
    <manufacturerName>Medytox Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000028153</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:38:50.215Z</lastUpdated>
  </row>
  <row>
    <udiDi>08806138000033</udiDi>
    <basicUdiDi>880613800003DA</basicUdiDi>
    <tradeName>Neuramis Deep Lidocaine</tradeName>
    <deviceName>Neuramis Deep Lidocaine</deviceName>
    <manufacturerName>Medytox Inc.</manufacturerName>
    <manufacturerSrn>KR-MF-000028153</manufacturerSrn>
    <authorisedRepresentativeName>Obelis s.a.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>BE-AR-000000106</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>N/A</reference>
    <placedOnMarketCountry>Sweden</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:38:49.052Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430809</udiDi>
    <basicUdiDi>B-08800259430809</basicUdiDi>
    <tradeName>Rabianca S</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPL100-27BC</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:36:38.124Z</lastUpdated>
  </row>
  <row>
    <udiDi>08800259430793</udiDi>
    <basicUdiDi>B-08800259430793</basicUdiDi>
    <tradeName>Rabianca S</tradeName>
    <deviceName>Sterile Absorbable Hyaluronic Acid Dermal Filler</deviceName>
    <manufacturerName>BioPlus Co., Ltd.</manufacturerName>
    <manufacturerSrn>KR-MF-000008618</manufacturerSrn>
    <authorisedRepresentativeName>KTR Europe GmbH</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>DE-AR-000005685</authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>X0303</emdnCode>
    <emdnDescription>SUBSTANCES, COMBINATIONS OF SUBSTANCES, OR ITEMS WITHOUT AN INTENDED MEDICAL PURPOSE INTENDED TO BE USED FOR FACIAL OR OTHER DERMAL OR MUCOUS MEMBRANE FILLING BY SUBCUTANEOUS, SUBMUCOUS OR INTRADERMAL INJECTION OR OTHER INTRODUCTION, BY A PREFILLED MEANS FOR INTRODUCTION, EXCLUDING THOSE FOR TATTOOING – RESORBABLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BPL100-27C</reference>
    <placedOnMarketCountry>Spain</placedOnMarketCountry>
    <lastUpdated>2026-07-01T02:36:35.725Z</lastUpdated>
  </row>
</eudamedExport>